ABSTRACT Two flat revertants have been isolated from mutagen-treated populations of Kirsten murine sarcoma virus (KiMuSV)-transformed NIH/3T3 cells. These revertants, which appear to be cellular variants resistant to transformation by the KiMuSV oncogene v-Ki-ras, contain Ki-MuSV-specific DNA, elevated levels of the v-Ki-ras gene product p2l, and rescuable transforming virus. Cell hybridization studies indicated that the revertant phenotype is dominant in hybrids between revertant cells and cells transformed by Ki-MuSV or the closely related Harvey MuSV and BALB MuSV. Analysis of hybrid cells resulting from the fusion of these revertants to cell lines transformed by other retroviruses showed that the action of certain oncogenes structurally unrelated to v-Ki-ras also could be suppressed. Thus, there appear to be functional relationships and diversities among transforming genes (oncogenes) not readily apparent from their structural characteristics.
Recent molecular studies have defined the structure of a number of transforming genes (oncogenes) and their products in considerable detail (reviewed in ref. 1) . All of the known retroviral oncogenes are closely related to sequences present in normal vertebrate cells (cellular proto-oncogenes), from which they appear to have arisen (1, 2) . The viral oncogenes associated with Kirsten and Harvey murine sarcoma viruses (Ki-and Ha-MuSVs), v-Ki-ras and v-Ha-ras, for example, are known to encode similar phosphorylated 21,000-dalton proteins (designated p2ls) with guanine nucleotide-binding activities (3) (4) (5) (6) . v-Ki-ras and v-Haras are structurally related to highly conserved cellular sequences (proto-oncogenes), some of which may be associated with the etiology of certain human tumors (refs. 7 and 8; reviewed in refs. 9 and 10).
In spite of the relatively large body of information concerning the molecular structure of retrovirus oncogenes and the proteins that they specify, comparatively little is known about the cellular components with which these proteins interact and the mechanism(s) by which they transform cells. The nature of the cellular components involved in the expression of transformation can be defined theoretically by the isolation and molecular characterization of flat nontransformed variants (revertants) from populations of retrovirus-transformed cells. Although a number of such flat revertants have been isolated from cells transformed by retroviruses (refs. 11-21; reviewed in ref. 22 ), the great majority of these has been shown to lack expression of functioning viral oncogenes. A few revertant cell lines containing apparent alterations in host cell genomes have been isolated (13, 21) ; however, little is known about the specific cellular factors involved in the reversion process.
This report describes two cellular revertants that are resistant to transformation by Ki-MuSV and certain other retroviruses. These revertants may be used to study the mechanism of transformation by the v-Ki-ras oncogene and to reveal functional relationships among different viral oncogenes, some of which cannot be predicted on the basis of their known structural characteristics.
MATERIALS AND METHODS Chemicals. Ouabain was obtained from Aldrich. Additional drugs were obtained from Sigma, unless otherwise specified.
Cell Lines. The murine cell lines used in this study were routinely passaged in Dulbecco-modified Eagle's medium supplemented with 10% fetal calf serum (GIBCO). The thymidine kinase-negative NIH cell line TK-NIH is a subclone of the N Cl-A Cl-10 line of BrdUrd-resistant NIH cells (R. Goldberg, personal communication). Ki/TK-NIH is a derivative of N Cl-A Cl-10 cells nonproductively transformed by Ki-MuSV. For use in some of the cell hybridization experiments, the revertant cell lines C-ll and F-2 as well as the TK-NIH cell line were first treated with the mutagen N-methyl-N'-nitro-N-nitrosoguanidine (9 ,uM for 4 hr) and then selected in medium containing 1 mM ouabain. The resulting lines were designated C-11ouR, F-2ouR, and TK-NIHouR, respectively.
Analysis of p2l Proteins. NaDodSO4 lysates prepared from equivalent numbers of cells were resolved by electrophoresis in 11% polyacrylamide (Bio-Rad) gels, and p21 was detected by standard protein blotting techniques (23) with a '5I-labeled antip21 monoclonal antibody. This antibody (provided by M. Furth, Sloan-Kettering Memorial Cancer Institute, New York, NY) recognizes both the Ki-and Ha-ras gene products (24) .
Cell Hybridization Mediated by Polyethylene Glycol. Cell hybrids were isolated by the method of Davidson and Gerald (25) . One million cells of each type to be hybridized were seeded in 60-mm plastic dishes and fused the following day by treatment for 1 min with 50% polyethylene glycol 6000 (Baker). After an additional 24 hr of incubation, the cells were trypsinized and plated in Dulbecco-modified Eagle's medium or 0.33% agar (Difco) medium (26) containing the selective agent HAT (hypoxanthine/aminopterin/thymidine) (27) § To whom reprint requests should be addressed.
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14-21 days of incubation by examination under an inverted microscope.
RESULTS AND DISCUSSION Few procedures have been described that are useful in selecting nontransformed revertants from mixed populations of predominantly transformed cells (15, 19, 28, 29) . In this study we used two strategies designed to facilitate the isolation of cellular revertants. First, a clone of NIH/3T3 cells containing two copies of the Ki-MuSV genome, the "DT" cell line, was used for the isolation of morphological revertants in order to minimize the number of flat revertants resulting simply from mutations in the v-ras gene. A second strategy was a result of the discovery that the DT cell line showed significantly lower colony-forming activity when plated in the presence of 1 mM ouabain than did its normal NIH/3T3 counterpart. Details of these procedures will be reported elsewhere.
Transformed DT cells were treated with the mutagen 5'-azacytidine (7 ug/ml for 24 hr) and allowed to recover for 7 days before being replated at a density of 105 cells per 60-mm dish; these cells were then treated with 1 mM ouabain for 48 hr. After 5 days of additional incubation, colonies composed of apparently flat cells were picked with cloning cylinders, expanded into mass cultures, and recloned in microtiter plates. Two such clones, C-li and F-2, were subjected to further study. Cells from the C-il revertant clone appeared to be flat and did not tend to pile up when cultured in liquid medium (Fig. IC) . Other properties of C-li and the second revertant, F-2, are shown in Table 1 . It is evident that these two revertant cell lines lost several other properties associated with transformation by the vKi-ras gene, including an ability to form tumors in nude mice and an ability to grow in soft agar. However, these cells retained an ability to grow in media containing low concentrations of serum. Still other properties, such as cell size, growth rate, and chromosome number, are not characteristic of either NIH/ 3T3 or DT cells.
A series of experiments designed to characterize the v-Ki-ras genes present in revertants C-li and F-2 was undertaken. The results of a Southern blot hybridization experiment demonstrated that both copies of the v-Ki-ras gene present in the original DT cell line are retained in the C-il and F-2 revertants without any gross rearrangements (unpublished data). In addition, the levels of the product of the v-Ki-ras gene, p21, were several fold higher in the two revertants than that routinely observed in normal NIH/3T3 cells (24) and approximated the levels observed in DT cells (Fig. 2 ). Because this result does not exclude the possibility that the p21 present in revertant cells is in some way functionally impaired, we attempted to "rescue" infectious Ki-MuSV by superinfecting the revertant cells with murine leukemia "helper" virus (MuLV) in an infectious center assay, the details of which have been published previously (31 vertant cells to normal NIH/3T3 cells resulted in hybrids that were.-flat, indicating that the-revertant phenotype does not result from the absence of some cellular component necessary for the transformation process. Therefore we were able to test the dominance of the revertant phenotype in hybrids by fusing the C-1l revertant cell line to TK-NIH cells transformed by KiMuSV (Ki/TK-NIH). The resulting hybrids were analyzed in liquid or semisolid medium containing HAT. The vast majority of hybrid cells formed in such experiments exhibited the nontransformed phenotype (Table 2 , line 1; Fig. 1D ). Similar results were obtained with the F-2 revertant. The results indicate that the revertant phenotype of both the C-il and F-2 lines is dominant over transformation by Ki-MuSV. It was considered important to analyze the results of fusion between the revertant lines reported here and additional rastransformed cells in order to confirm and extend our initial ,findings. Fusion of each of the revertant cell lines to a variety of transformed cells was facilitated by use of the selection system devised by Jha and Ozer (2-2). Doubly marked (TGRouR) derivatives of the C-1l and F-2 revertants were fused to each of four additional cell.lines transformed by Ki-MuSV and the closely related Ha-MuSV and BALB-MuSV (33) (Table' 2). The frequency of transformation was assessed in both liquid and semisolid medium in the presence of both HAT and ouabain. In each case the transformed cell line was also fused to normal NIH/3T3 cells, and the ability of the revertant to suppress transformation was expressed as. a ratio of the two frequencies. Table 2 , and the resulting hybrids were. selected in Table 2 . Thus, revertants C-1l and F-2 are able to suppress transformation by v-Ki-ras and related oncogenes. Interestingly, transformation by an activated human oncogene c-Ha-ras 1 (human) (36) also is suppressed after fusion to revertant C-11ouR (able 2).
Results obtained by fusion of revertant and transformed cell lines must be interpreted with caution. It is well known that fusion of phenotypically flat cells (other than revertants) with transformed cells can often give rise to hybrid cells exhibiting a nontransformed-phenotype (22, 37, 38) . However, Ki-MuSV is able to transform NIH/3T3 cells efficiently-at high multi, plicities of infection, essentially all of. the cells in a population are transformed. Moreover, the results of repeated control fu-.-sion experiments (not shown) indicated that the transformed phenotype is clearly dominant in hybrids between Ki-MuSVtransformed cells. and NIH/3T3 cells. These two linesof evi--dence imply that there is no significant suppression of Ki-MuSVrelated transformation by normal NIH/3T3 cells.
The specific suppression of Ki-MuSV-related transformation in the C-lI and F-2 cell lines and their hybrids permitted an analysis of the suppression of other transforming agents by these revertants. Therefore, we undertook to determine whether or not the suppression of transformed-phenotypes by the revertants is limited to ras-related transformation. C_11ouR cells were hybridized to mouse cells transformed by a variety of agents (Table 3) by essentially the same procedure as that used in Table 2 . The data are again expressed as ratios between the frequency of transformed colonies observed after fusion to normal cells (TK.NIHouR) and the frequency of transformed colonies observed after fusion to the revertant cells (C11ouR). The results (Table 3 ) reveal several interesting phenomena. First, it is clear that suppression of transformation by the C-1l revertant cells is not limited to hybrids derived from cells transformed by ras-related oncogenes. In particular, transformation by fes, and possibly by src (see below), is suppressed, whereas transformations by mos, fns, and sis are not suppressed. Second, the suppression pattern is consistent for each oncogene-all cell lines transformed by a given oncogene and its structural relatives behave in the same manner, except for src.
The transformed phenotype in two of the four src-transformed cell.lines (SR/NIH and B77/BALB) is suppressed in hybrids with-"normal" NIH cells and with the C-il revertant. Transformation in the other two src-containing cell lines is suppressed in hybrids with the C-li revertant but not in hybrids with normal NIH cells. Suppression of src-related transformation in hybrids involving "normal" Swiss mouse.cells has been reported (37, 38) . This type of suppression may involve an inhibition of viral RNA or protein synthesis, or both, by normal mouse cells (38) .. Interestingly,-Rous sarcoma virus is the only retrovirus .examined in this study that does not transform mammalian cells efficiently (45) . It seems likely, therefore, that the suppression of src in hybrids with the revertant^C-11 may in some cases result from a distinctly different mechanism than does the suppression of other oncogenes.
A duplicate series-of experiments with the F-2 revertant gave similar results to those reported in Table 3 . Thus, with the exception of the src gene noted above, suppression of transformed phenotypes by these revertants appears to be a highly reproducible phenomenon with regard to each oncogene and its structural relatives. However, the pattern of suppression of different oncogenes cannot-be predicted solely on the basis of structural similarities. This fact, together with the data reported in Table 1 , suggests that the C-il and F-2 revertants possess-alterations in their cellular genomes that allow them to block the Ki-MuSV-induced transformation process at some point distal to the initial interaction of p21 with its target molecule(s).
As a result, the activities of the protein products of other oncogenes may or may not be suppressed by these revertants, depending on their functional interactions within cells. In this regard, the fes-transforming protein, P1089aa-fes, appears to be present in undiminished amounts in nontransformed hybrids between the revertants and fes-transformed NIH/3T3 cells (S. J. Anderson & C. Sherr, personal communication). Because the fes gene product, P108gag-fes and the ras gene product, p21, bear no obvious structural similarities to one another, suppression may be based on other similarities, perhaps reflecting a commonality in the pathways by which these molecules transform cells.
Revertants such as the C-il and F-2 cell lines reported here may be useful for detecting relationships among oncogenes not evident from their structural characteristics, for identifying and classifying oncogenes in tumor cells by their relationships to known oncogenes, and for characterizing the cellular constituents with which the products of oncogenes interact. Current studies are directed towards an understanding of the revertant phenotype with regard to ouabain resistance, the identification of the genetic alteration responsible for reversion, and the gen- 
